In the BioHarmony Drug Report Database

"Preview" Icon

Ropinirole

Requip, Requip Xl (ropinirole) is a small molecule pharmaceutical. Ropinirole was first approved as Requip on 1997-09-19. It is used to treat parkinson disease in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. Requip’s patents are valid until 2021-12-02 (FDA).

 

Trade Name

 

Requip, Requip Xl
 

Common Name

 

ropinirole
 

ChEMBL ID

 

CHEMBL589
 

Indication

 

parkinson disease
 

Drug Class

 

Image (chem structure or protein)

Ropinirole structure rendering